Global Lung Cancer Diagnostic Tests Market Size, Industry Analysis By Segmentations, Top Key Players, Trends, Future Development & Forecast 2024-2035
- PUBLISHED ON
- 3/1/2023
- NO OF PAGES
- 290
- CATEGORY
- Healthcare & Life Sciences
Lung Cancer Diagnostic Tests market report presents a global overview of market shares, size, statistics, trends, demand, revenue and growth opportunities by key players, regions and countries. This report offers a complete market overview during the past, present, and the forecast period till 2032 which helps to identify future opportunities, risk factors, growing areas. Report also highlight on recent developments, technological innovations, market affecting factors, demographics analysis, demand and supply chain which gives brief strategy of market growth during the forecast period. It also gives in-depth insights on SWOT and PESTLE analysis based on industry segmentations and regional developments.
Market Overview:
The report provides a basic overview of the industry including definitions, classifications, and industry chain structure. The Lung Cancer Diagnostic Tests market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand, price, revenue and gross margins.
Report Scope:
The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Lung Cancer Diagnostic Tests manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases. The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment by type, application and region and as a result provides a holistic view of as well as a deep insight into the Lung Cancer Diagnostic Tests market covering all its essential aspects.
Global Lung Cancer Diagnostic Tests Market: Segmentations
Global Lung Cancer Diagnostic Tests Market: By Types
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other Diagnostics Methods
Global Lung Cancer Diagnostic Tests Market: By Applications
Precision Medicine
Personalized Medicine
Cancer Monitoring
Global Lung Cancer Diagnostic Tests Market: Major Players
Advpharma Inc
AIT Austrian Institute of Technology GmbH
Courtagen Life Sciences Inc
DiagnoCure Inc. (Inactive)
BioMark Diagnostics Inc.
BioMarker Strategies LLC
Emory University
Epigenomics AG
GlycoZym
HalioDx SAS
Louisville Bioscience, Inc.
Mayo Clinic US
Global Lung Cancer Diagnostic Tests Market: By Regions
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Key Benefits:
• The analysis provides an overview of the factors driving and limiting the growth of the market including trends, structure and others.
• Market estimation for type and geographic segments is derived from the current market scenario and expected market trends.
• Porter’s Five Force Model and SWOT analysis are used to study the global Lung Cancer Diagnostic Tests market and would help stakeholders make strategic decisions.
• The analysis assists in understanding the strategies adopted by the companies for the growth of this market.
• In-depth analysis of the types of Lung Cancer Diagnostic Tests would help in identifying future applications in this market.
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Objectives of the Study:
• To provide with an exhaustive analysis on the Lung Cancer Diagnostic Tests Market by Product, By Application, By End User and by Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Base Year: 2023Market Overview:
The report provides a basic overview of the industry including definitions, classifications, and industry chain structure. The Lung Cancer Diagnostic Tests market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand, price, revenue and gross margins.
Report Scope:
The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Lung Cancer Diagnostic Tests manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases. The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment by type, application and region and as a result provides a holistic view of as well as a deep insight into the Lung Cancer Diagnostic Tests market covering all its essential aspects.
Global Lung Cancer Diagnostic Tests Market: Segmentations
Global Lung Cancer Diagnostic Tests Market: By Types
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other Diagnostics Methods
Global Lung Cancer Diagnostic Tests Market: By Applications
Precision Medicine
Personalized Medicine
Cancer Monitoring
Global Lung Cancer Diagnostic Tests Market: Major Players
Advpharma Inc
AIT Austrian Institute of Technology GmbH
Courtagen Life Sciences Inc
DiagnoCure Inc. (Inactive)
BioMark Diagnostics Inc.
BioMarker Strategies LLC
Emory University
Epigenomics AG
GlycoZym
HalioDx SAS
Louisville Bioscience, Inc.
Mayo Clinic US
Global Lung Cancer Diagnostic Tests Market: By Regions
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Key Benefits:
• The analysis provides an overview of the factors driving and limiting the growth of the market including trends, structure and others.
• Market estimation for type and geographic segments is derived from the current market scenario and expected market trends.
• Porter’s Five Force Model and SWOT analysis are used to study the global Lung Cancer Diagnostic Tests market and would help stakeholders make strategic decisions.
• The analysis assists in understanding the strategies adopted by the companies for the growth of this market.
• In-depth analysis of the types of Lung Cancer Diagnostic Tests would help in identifying future applications in this market.
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Objectives of the Study:
• To provide with an exhaustive analysis on the Lung Cancer Diagnostic Tests Market by Product, By Application, By End User and by Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Historic Year: 2016-2022
Forecast: 2024-2035
1 Market Overview
1.1 Product Overview and Scope of Lung Cancer Diagnostic Tests
1.2 Classification of Lung Cancer Diagnostic Tests by Type
1.2.1 Overview: Global Lung Cancer Diagnostic Tests Market Size by Type: 2017 Versus 2022 Versus 2032
1.2.2 Global Lung Cancer Diagnostic Tests Revenue Market Share by Type in 2022
1.2.3 Immunoassays
1.2.4 Flow Cytometry
1.2.5 Rapid Tests
1.2.6 Molecular Assays
1.2.7 Tissue Arrays
1.2.8 Circulating Tumor Cells
1.2.9 Pharmacodiagnostics
1.2.10 Biomarkers
1.2.11 Other Diagnostics Methods
1.3 Global Lung Cancer Diagnostic Tests Market by Application
1.3.1 Overview: Global Lung Cancer Diagnostic Tests Market Size by Application: 2017 Versus 2022 Versus 2032
1.3.2 Precision Medicine
1.3.3 Personalized Medicine
1.3.4 Cancer Monitoring
1.4 Global Lung Cancer Diagnostic Tests Market Size & Forecast
1.5 Global Lung Cancer Diagnostic Tests Market Size and Forecast by Region
1.5.1 Global Lung Cancer Diagnostic Tests Market Size by Region: 2017 VS 2022 VS 2032
1.5.2 Global Lung Cancer Diagnostic Tests Market Size by Region, (2016-2021)
1.5.3 North America Lung Cancer Diagnostic Tests Market Size and Prospect (2017-2032)
1.5.4 Europe Lung Cancer Diagnostic Tests Market Size and Prospect (2017-2032)
1.5.5 Asia-Pacific Lung Cancer Diagnostic Tests Market Size and Prospect (2017-2032)
1.5.6 South America Lung Cancer Diagnostic Tests Market Size and Prospect (2017-2032)
1.5.7 Middle East and Africa Lung Cancer Diagnostic Tests Market Size and Prospect (2017-2032)
1.6 Market Drivers, Restraints and Trends
1.6.1 Lung Cancer Diagnostic Tests Market Drivers
1.6.2 Lung Cancer Diagnostic Tests Market Restraints
1.6.3 Lung Cancer Diagnostic Tests Trends Analysis
2 Company Profiles
2.1 Advpharma Inc
2.1.1 Advpharma Inc Details
2.1.2 Advpharma Inc Major Business
2.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Product and Solutions
2.1.4 Advpharma Inc Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 Advpharma Inc Recent Developments and Future Plans
2.2 AIT Austrian Institute of Technology GmbH
2.2.1 AIT Austrian Institute of Technology GmbH Details
2.2.2 AIT Austrian Institute of Technology GmbH Major Business
2.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product and Solutions
2.2.4 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 AIT Austrian Institute of Technology GmbH Recent Developments and Future Plans
2.3 Courtagen Life Sciences Inc
2.3.1 Courtagen Life Sciences Inc Details
2.3.2 Courtagen Life Sciences Inc Major Business
2.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product and Solutions
2.3.4 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 Courtagen Life Sciences Inc Recent Developments and Future Plans
2.4 DiagnoCure Inc. (Inactive)
2.4.1 DiagnoCure Inc. (Inactive) Details
2.4.2 DiagnoCure Inc. (Inactive) Major Business
2.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product and Solutions
2.4.4 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 DiagnoCure Inc. (Inactive) Recent Developments and Future Plans
2.5 BioMark Diagnostics Inc.
2.5.1 BioMark Diagnostics Inc. Details
2.5.2 BioMark Diagnostics Inc. Major Business
2.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product and Solutions
2.5.4 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 BioMark Diagnostics Inc. Recent Developments and Future Plans
2.6 BioMarker Strategies LLC
2.6.1 BioMarker Strategies LLC Details
2.6.2 BioMarker Strategies LLC Major Business
2.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product and Solutions
2.6.4 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 BioMarker Strategies LLC Recent Developments and Future Plans
2.7 Emory University
2.7.1 Emory University Details
2.7.2 Emory University Major Business
2.7.3 Emory University Lung Cancer Diagnostic Tests Product and Solutions
2.7.4 Emory University Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 Emory University Recent Developments and Future Plans
2.8 Epigenomics AG
2.8.1 Epigenomics AG Details
2.8.2 Epigenomics AG Major Business
2.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Product and Solutions
2.8.4 Epigenomics AG Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 Epigenomics AG Recent Developments and Future Plans
2.9 GlycoZym
2.9.1 GlycoZym Details
2.9.2 GlycoZym Major Business
2.9.3 GlycoZym Lung Cancer Diagnostic Tests Product and Solutions
2.9.4 GlycoZym Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 GlycoZym Recent Developments and Future Plans
2.10 HalioDx SAS
2.10.1 HalioDx SAS Details
2.10.2 HalioDx SAS Major Business
2.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Product and Solutions
2.10.4 HalioDx SAS Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 HalioDx SAS Recent Developments and Future Plans
2.11 Louisville Bioscience, Inc.
2.11.1 Louisville Bioscience, Inc. Details
2.11.2 Louisville Bioscience, Inc. Major Business
2.11.3 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Product and Solutions
2.11.4 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.11.5 Louisville Bioscience, Inc. Recent Developments and Future Plans
2.12 Mayo Clinic US
2.12.1 Mayo Clinic US Details
2.12.2 Mayo Clinic US Major Business
2.12.3 Mayo Clinic US Lung Cancer Diagnostic Tests Product and Solutions
2.12.4 Mayo Clinic US Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.12.5 Mayo Clinic US Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Lung Cancer Diagnostic Tests Revenue and Share by Players (2017-2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Lung Cancer Diagnostic Tests Players Market Share
3.2.2 Top 10 Lung Cancer Diagnostic Tests Players Market Share
3.2.3 Market Competition Trend
3.3 Lung Cancer Diagnostic Tests Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Lung Cancer Diagnostic Tests Revenue and Market Share by Type (2016-2021)
4.2 Global Lung Cancer Diagnostic Tests Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Lung Cancer Diagnostic Tests Revenue Market Share by Application (2016-2021)
5.2 Lung Cancer Diagnostic Tests Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Lung Cancer Diagnostic Tests Revenue by Type (2017-2032)
6.2 North America Lung Cancer Diagnostic Tests Revenue by Application (2017-2032)
6.3 North America Lung Cancer Diagnostic Tests Market Size by Country
6.3.1 North America Lung Cancer Diagnostic Tests Revenue by Country (2017-2032)
6.3.2 United States Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
6.3.3 Canada Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
6.3.4 Mexico Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
7 Europe by Country, by Type, and by Application
7.1 Europe Lung Cancer Diagnostic Tests Revenue by Type (2017-2032)
7.2 Europe Lung Cancer Diagnostic Tests Revenue by Application (2017-2032)
7.3 Europe Lung Cancer Diagnostic Tests Market Size by Country
7.3.1 Europe Lung Cancer Diagnostic Tests Revenue by Country (2017-2032)
7.3.2 Germany Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
7.3.3 France Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
7.3.4 United Kingdom Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
7.3.5 Russia Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
7.3.6 Italy Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Lung Cancer Diagnostic Tests Revenue by Type (2017-2032)
8.2 Asia-Pacific Lung Cancer Diagnostic Tests Revenue by Application (2017-2032)
8.3 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Region
8.3.1 Asia-Pacific Lung Cancer Diagnostic Tests Revenue by Region (2017-2032)
8.3.2 China Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
8.3.3 Japan Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
8.3.4 South Korea Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
8.3.5 India Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
8.3.6 Southeast Asia Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
8.3.7 Australia Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
9 South America by Country, by Type, and by Application
9.1 South America Lung Cancer Diagnostic Tests Revenue by Type (2017-2032)
9.2 South America Lung Cancer Diagnostic Tests Revenue by Application (2017-2032)
9.3 South America Lung Cancer Diagnostic Tests Market Size by Country
9.3.1 South America Lung Cancer Diagnostic Tests Revenue by Country (2017-2032)
9.3.2 Brazil Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
9.3.3 Argentina Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Lung Cancer Diagnostic Tests Revenue by Type (2017-2032)
10.2 Middle East & Africa Lung Cancer Diagnostic Tests Revenue by Application (2017-2032)
10.3 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country
10.3.1 Middle East & Africa Lung Cancer Diagnostic Tests Revenue by Country (2017-2032)
10.3.2 Turkey Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
10.3.3 Saudi Arabia Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
10.3.4 UAE Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Lung Cancer Diagnostic Tests
1.2 Classification of Lung Cancer Diagnostic Tests by Type
1.2.1 Overview: Global Lung Cancer Diagnostic Tests Market Size by Type: 2017 Versus 2022 Versus 2032
1.2.2 Global Lung Cancer Diagnostic Tests Revenue Market Share by Type in 2022
1.2.3 Immunoassays
1.2.4 Flow Cytometry
1.2.5 Rapid Tests
1.2.6 Molecular Assays
1.2.7 Tissue Arrays
1.2.8 Circulating Tumor Cells
1.2.9 Pharmacodiagnostics
1.2.10 Biomarkers
1.2.11 Other Diagnostics Methods
1.3 Global Lung Cancer Diagnostic Tests Market by Application
1.3.1 Overview: Global Lung Cancer Diagnostic Tests Market Size by Application: 2017 Versus 2022 Versus 2032
1.3.2 Precision Medicine
1.3.3 Personalized Medicine
1.3.4 Cancer Monitoring
1.4 Global Lung Cancer Diagnostic Tests Market Size & Forecast
1.5 Global Lung Cancer Diagnostic Tests Market Size and Forecast by Region
1.5.1 Global Lung Cancer Diagnostic Tests Market Size by Region: 2017 VS 2022 VS 2032
1.5.2 Global Lung Cancer Diagnostic Tests Market Size by Region, (2016-2021)
1.5.3 North America Lung Cancer Diagnostic Tests Market Size and Prospect (2017-2032)
1.5.4 Europe Lung Cancer Diagnostic Tests Market Size and Prospect (2017-2032)
1.5.5 Asia-Pacific Lung Cancer Diagnostic Tests Market Size and Prospect (2017-2032)
1.5.6 South America Lung Cancer Diagnostic Tests Market Size and Prospect (2017-2032)
1.5.7 Middle East and Africa Lung Cancer Diagnostic Tests Market Size and Prospect (2017-2032)
1.6 Market Drivers, Restraints and Trends
1.6.1 Lung Cancer Diagnostic Tests Market Drivers
1.6.2 Lung Cancer Diagnostic Tests Market Restraints
1.6.3 Lung Cancer Diagnostic Tests Trends Analysis
2 Company Profiles
2.1 Advpharma Inc
2.1.1 Advpharma Inc Details
2.1.2 Advpharma Inc Major Business
2.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Product and Solutions
2.1.4 Advpharma Inc Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 Advpharma Inc Recent Developments and Future Plans
2.2 AIT Austrian Institute of Technology GmbH
2.2.1 AIT Austrian Institute of Technology GmbH Details
2.2.2 AIT Austrian Institute of Technology GmbH Major Business
2.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product and Solutions
2.2.4 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 AIT Austrian Institute of Technology GmbH Recent Developments and Future Plans
2.3 Courtagen Life Sciences Inc
2.3.1 Courtagen Life Sciences Inc Details
2.3.2 Courtagen Life Sciences Inc Major Business
2.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product and Solutions
2.3.4 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 Courtagen Life Sciences Inc Recent Developments and Future Plans
2.4 DiagnoCure Inc. (Inactive)
2.4.1 DiagnoCure Inc. (Inactive) Details
2.4.2 DiagnoCure Inc. (Inactive) Major Business
2.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product and Solutions
2.4.4 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 DiagnoCure Inc. (Inactive) Recent Developments and Future Plans
2.5 BioMark Diagnostics Inc.
2.5.1 BioMark Diagnostics Inc. Details
2.5.2 BioMark Diagnostics Inc. Major Business
2.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product and Solutions
2.5.4 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 BioMark Diagnostics Inc. Recent Developments and Future Plans
2.6 BioMarker Strategies LLC
2.6.1 BioMarker Strategies LLC Details
2.6.2 BioMarker Strategies LLC Major Business
2.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product and Solutions
2.6.4 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 BioMarker Strategies LLC Recent Developments and Future Plans
2.7 Emory University
2.7.1 Emory University Details
2.7.2 Emory University Major Business
2.7.3 Emory University Lung Cancer Diagnostic Tests Product and Solutions
2.7.4 Emory University Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 Emory University Recent Developments and Future Plans
2.8 Epigenomics AG
2.8.1 Epigenomics AG Details
2.8.2 Epigenomics AG Major Business
2.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Product and Solutions
2.8.4 Epigenomics AG Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 Epigenomics AG Recent Developments and Future Plans
2.9 GlycoZym
2.9.1 GlycoZym Details
2.9.2 GlycoZym Major Business
2.9.3 GlycoZym Lung Cancer Diagnostic Tests Product and Solutions
2.9.4 GlycoZym Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 GlycoZym Recent Developments and Future Plans
2.10 HalioDx SAS
2.10.1 HalioDx SAS Details
2.10.2 HalioDx SAS Major Business
2.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Product and Solutions
2.10.4 HalioDx SAS Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 HalioDx SAS Recent Developments and Future Plans
2.11 Louisville Bioscience, Inc.
2.11.1 Louisville Bioscience, Inc. Details
2.11.2 Louisville Bioscience, Inc. Major Business
2.11.3 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Product and Solutions
2.11.4 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.11.5 Louisville Bioscience, Inc. Recent Developments and Future Plans
2.12 Mayo Clinic US
2.12.1 Mayo Clinic US Details
2.12.2 Mayo Clinic US Major Business
2.12.3 Mayo Clinic US Lung Cancer Diagnostic Tests Product and Solutions
2.12.4 Mayo Clinic US Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2017-2022)
2.12.5 Mayo Clinic US Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Lung Cancer Diagnostic Tests Revenue and Share by Players (2017-2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Lung Cancer Diagnostic Tests Players Market Share
3.2.2 Top 10 Lung Cancer Diagnostic Tests Players Market Share
3.2.3 Market Competition Trend
3.3 Lung Cancer Diagnostic Tests Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Lung Cancer Diagnostic Tests Revenue and Market Share by Type (2016-2021)
4.2 Global Lung Cancer Diagnostic Tests Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Lung Cancer Diagnostic Tests Revenue Market Share by Application (2016-2021)
5.2 Lung Cancer Diagnostic Tests Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Lung Cancer Diagnostic Tests Revenue by Type (2017-2032)
6.2 North America Lung Cancer Diagnostic Tests Revenue by Application (2017-2032)
6.3 North America Lung Cancer Diagnostic Tests Market Size by Country
6.3.1 North America Lung Cancer Diagnostic Tests Revenue by Country (2017-2032)
6.3.2 United States Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
6.3.3 Canada Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
6.3.4 Mexico Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
7 Europe by Country, by Type, and by Application
7.1 Europe Lung Cancer Diagnostic Tests Revenue by Type (2017-2032)
7.2 Europe Lung Cancer Diagnostic Tests Revenue by Application (2017-2032)
7.3 Europe Lung Cancer Diagnostic Tests Market Size by Country
7.3.1 Europe Lung Cancer Diagnostic Tests Revenue by Country (2017-2032)
7.3.2 Germany Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
7.3.3 France Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
7.3.4 United Kingdom Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
7.3.5 Russia Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
7.3.6 Italy Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Lung Cancer Diagnostic Tests Revenue by Type (2017-2032)
8.2 Asia-Pacific Lung Cancer Diagnostic Tests Revenue by Application (2017-2032)
8.3 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Region
8.3.1 Asia-Pacific Lung Cancer Diagnostic Tests Revenue by Region (2017-2032)
8.3.2 China Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
8.3.3 Japan Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
8.3.4 South Korea Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
8.3.5 India Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
8.3.6 Southeast Asia Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
8.3.7 Australia Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
9 South America by Country, by Type, and by Application
9.1 South America Lung Cancer Diagnostic Tests Revenue by Type (2017-2032)
9.2 South America Lung Cancer Diagnostic Tests Revenue by Application (2017-2032)
9.3 South America Lung Cancer Diagnostic Tests Market Size by Country
9.3.1 South America Lung Cancer Diagnostic Tests Revenue by Country (2017-2032)
9.3.2 Brazil Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
9.3.3 Argentina Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Lung Cancer Diagnostic Tests Revenue by Type (2017-2032)
10.2 Middle East & Africa Lung Cancer Diagnostic Tests Revenue by Application (2017-2032)
10.3 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country
10.3.1 Middle East & Africa Lung Cancer Diagnostic Tests Revenue by Country (2017-2032)
10.3.2 Turkey Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
10.3.3 Saudi Arabia Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
10.3.4 UAE Lung Cancer Diagnostic Tests Market Size and Forecast (2017-2032)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Pricing
Select a license type that suits your business needs
Single User Access
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
Multi User Cost
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
Enterprise User Cost
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI